3Ohrmann P, Siegmund A, Suslow T, et al. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic re- sonance spectroscopy study[J]. J Psychiatr Res, 2007,41(8):625- 634.
4Shimizu E, Hashimoto K, Ochi S, et al. Posterior cingulate gyms metabolic changes in chronic schizophrenia with generalized co- gnitive deficits[J]. J Psychiatr Res, 2007,41(1):49-56.
5Szulc A, Galiflska B, Tarasow E, et al. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neurolepties: a proton magnetic resonance spectroscopy (tH-MRS) study[J]. Med Sci Monit, 2007,130):17-22.
6Szulc A, Galifiska B, Tarasow E, et al. The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study[J]. Psychiatr Pol, 2010, 44(3):415-426.
7Bustillo JR, Rowland LM, Mullins P, et al. ^1H-MRS at 4 Tesla in minimally treated early schizophrenia[J]. Mol Psychiatry, 2010, 15(6):626-636.
8Ross A J, Sachdev PS. Magnetic resonance spectroscopy in co- gnitive research[J]. Brain Res Brain Res Rev, 2004,44(2/3):83- 102.
